Cannabis
Why Join our monthly Salons:
- Participate in interactive session for brainstorming with experts and peers
- Access recordings of sessions for revisiting key points
- Choose from multiple round table discussions every month
- Gain concrete take-aways for immediate implementation
Learning By Conversation
Monthly Schedule
January: Discussion on Politics of Cannabis Treatment
- Discuss the cannabis plant and what it contains
- Explain opportunities for pharmacies
- Review where you can find Cannabinoid Education – Source
February: Utilizing Cannabis as A Therapy for Chronic Pain Management
- Understand the difference and medical benefits of THC vs CBD
- Learn how to identify effective off the shelf products
- Examine established protocols for pain management and dosing
- Address arguments against cannabis for pain management
March: Regulatory Update: Hemp – 2018 US Farm Bill – Delta 8 THC, Delta 9 THC, Delta 10 THC
- Review ways to talk to patients and medical professionals on differences between Delta 8, 9 and 10
- Asses if there is a need for the different deltas being developed into specific and targeted applications
- Identify a wish list of what policymakers should know about Delta 8, 9, and 10?
April: Different Q/A Thresholds In Different State Markets
- Initial and Current State of Q/A Testing
- State to State Variance
- Transition to a Consistent, Federally Regulated Q/A Testing Program
May: Improving Patient Accessibility While Mitigating Black Market Appeal
- Examine how price and supply are driving factors in accessibility pain points
- Look at how civil rights is negatively effecting veterans and patients
- Demonstrate government stigma and the consequences
June: Risks to Patients that Need to Be Considered
- Examine potential criminal, civil and employment consequences to patients when things go wrong
- Review negative impact of THC and CBD on certain patient populations and how to avoid them
- Examine potential interactions and side effects of medicines
July: Using Data from State Prescription Drug Management Program To Show Reduction On Opioid Use In Lieu Of Cannabis
TBA
Who Should Attend
Quality Assurance | General Counsel |
Quality Control | Pharmacy Services |
Pharmacy Operations | Facilities Management |
Owner / President / CEO | Supervising pharmacist or non-pharmacist manager equivalent |
Compliance | Facility manager |
Policy and Regulatory Affairs | Infection control lead |
Legal | Process improvement |
Industries
503A Compounding Pharmacies | Community Pharmacies |
503B Compounding Pharmacies | Specialty Pharmacies |
Hospital Pharmacies | Nuclear Pharmacies |
Cannabis | Pharmacogenomics |